Navigation Links
Experts Divided on Whether to Treat Thyroid Cancer

Study suggests quick action makes little difference, but others call this risky

MONDAY, May 17 (HealthDay News) -- Immediate treatment of thyroid cancer that has not spread beyond the gland doesn't make much difference in long-term survival, according to a study that quickly aroused controversy.

"One thing that really surprised me was how good survival was," said Dr. Louise Davies, lead author of a report on the study, published in the May issue of Archives of Otolaryngology. "We found that for cancers of any size that are confined to the gland, the 20-year survival rate for those that got immediate treatment was 99 percent, and for those not treated immediately, in the first year or even longer after diagnosis, 20-year survival was 97 percent."

That finding "led me as a surgeon to think about the risks versus the benefits of surgery for such thyroid cancers," Davies said. "It certainly made me feel a lot less anxious about working with these patients to watch small thyroid modules and not biopsy every one. I'm a lot less worried than I used to be that there will be a cancer in that module that is going to kill a person."

That conclusion drew a quick rebuttal from Dr. Erich M. Sturgis, an associate professor of head and neck surgery at the M.D. Anderson Cancer Center and co-author of an accompanying editorial.

"Our concern is that a general person reading that paper will draw the conclusion that there is no size limit to a tumor of that gland that can be observed rather than treated," Sturgis said.

Davies, an assistant professor of surgery in the Dartmouth Medical School section of otolaryngology and a staff surgeon at the Veterans Affairs Medical Center in White River Junction, Vt., was also the author of a 2006 report that started an ongoing controversy about the incidence of thyroid cancer in the United States. That paper reported a sharp increase in the number of thyroid cancers being diagnosed, and oncologists are still divided about whether the increase should be attributed to overdiagnosis or some unknown factor.

About 37,000 new cases of thyroid cancer are diagnosed each year in the United States, and about 1,600 people die from the disease each year, according to National Cancer Institute estimates.

In the new study, Davies and her colleagues used a national data base to compare 35,223 people diagnosed with thyroid cancer who had immediate radiation treatment or surgery with 440 who did not. The 20-year survival rates were determined by projecting the death rates in the two groups over periods of six to eight years.

Davies said the finding has led her to restrict treatment to people where there were signs of danger -- difficulty swallowing, changes of voice (the thyroid gland is in the neck), radiation exposure to the head and neck or a family history of the cancer.

"For those patients, the risk of surgery is outweighed by the benefits," Davies said.

However, Sturgis contends that the conclusion of the new study is flawed because the national data base provides incomplete information. "Sometimes patients may have had unconventional treatment that doesn't get coded," he said. "For example, removal of a nodule may get coded as a biopsy."

Overdiagnosis of thyroid cancer does appear to be a problem, Sturgis said, and many biopsies -- tissues samples -- are being done when they shouldn't be. Current guidelines say that nodules less than 1 centimeter in size should be followed by imaging rather than by biopsies, he said.

Age is one factor in deciding whether to treat or observe that is not mentioned in the new study, Sturgis said. "An elderly patient with a small nodule is different from a young patient with a small nodule," he said.

And though the difference in survival over 20 years is only 2 percent, "treatment is better than observation, although it is a small difference," Sturgis said.

Dr. J. Leonard Lichtenfeld, deputy chief medical officer of the American Cancer Society, described the study as "thought-provoking," but said the conclusion that so many thyroid cancers can be left untreated is "risky."

"The numbers are simply too small, and there are so many unanswered questions to justify a physician saying to a patient, 'It won't hurt you if we just follow this cancer,' " Lichtenfeld said. "That would require a completely different kind of study."

More information

To learn more about thyroid cancer, visit the U.S. National Cancer Institute.

SOURCES: Louise Davies, M.D., M.S., associate professor, otolaryngology surgery, Dartmouth Medical School, Hanover, N.H., and staff surgeon, White River Veterans Affairs Medical Center, White River Junction, Vt.; Erich M. Sturgis, M.D., associate professor, head and neck surgery, M.D. Anderson Cancer Center, Houston; J. Leonard Lichtenfeld, M.D., M.A.C.P., deputy chief medical officer, American Cancer Society, Atlanta; May 2010, Archives of Otolaryngology

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Informatics experts contribute to special Health Affairs edition on e-health in the developing world
2. As Swine Flu Fades, Experts Ponder Next Season
3. Peer Review Experts Have Weighed In ... WEIGHLEVEL Is a Proven Winner
4. Chiropractors at Lyn Lake Chiropractic Clinic Provide Minneapolis, MN, Resource As Official ASK THE EXPERTS Sponsor
5. Experts Issue Warning on Prostate Hormone Therapy
6. Ask the non-experts
7. Experts Push 7 Steps to Heart Health
8. Life-Saving Emergency Supplies and Experts Arrive in Port-au-Prince
9. Transplant infectious disease experts provide pandemic guidance
10. Experts Say CPR by Untrained Bystander a Good Idea
11. Airport Full Body Scanners Pose No Health Threat: Experts
Post Your Comments:
(Date:11/25/2015)... ... ... In an ongoing Clinical Study conducted by an independent physician, Andrew Gostine, ... evaluating the efficacy of its product and its disinfection protocol. This study is taking ... 2014 through October 2015 at a 360-bed, acute-care, academic medical center located in Chicago, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... 25, 2015 , ... Many people know of the common symptoms of low ... dry skin. But many people who find their cholesterol levels and weight are creeping ... thyroid, especially if they don’t have any of the other symptoms. , Thyroid hormone ...
(Date:11/25/2015)... ... November 25, 2015 , ... Bunion ... in an early celebration of the early holiday shopping season. Starting Wednesday November ... (normally $33.95 ea). Black Friday promotional pricing is in addition to any automatic ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 2015  Thanks to a donor with a personal ... Center,s Sister Diane Grassilli Center for Women,s Health now ... San Francisco . Fred ... with a gift of $617,320 that allowed the Center ... Tomosynthesis and Whole Breast Ultrasound. Tomosynthesis, three-dimensional (3-D) mammography ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" ... announced today that the first patient has been enrolled ... a treatment for metastatic castration-resistant prostate cancer ("mCRPC"). ... --> the United States ... Phase 1/2 clinical trial, ESSA intends to demonstrate the ...
(Date:11/24/2015)... PUNE, India , November 24, 2015 ... new market research report "Spine Biologics Market by Product Type ... Type (Anterior Cervical Discectomy and Fusion, Posterior Lumbar Interbody Fusion), ... by MarketsandMarkets, the global market was valued at $1.90 Billion ... 2020, at a CAGR of 4.4% during the forecast period ...
Breaking Medicine Technology: